Last $8.28 USD
Change Today +0.01 / 0.12%
Volume 546.9K
SPPI On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 06/18/13 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Brett L. Scott CPA

Senior Vice President of Finance, Spectrum Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

61$546,814
As of Fiscal Year 2012

Background*

Mr. Brett L. Scott, CPA has been Senior Vice President of Finance at Spectrum Pharmaceuticals, Inc. since June 5, 2013. Previously, Mr. Scott served as an Acting Chief Financial Officer and Senior Vice President at Spectrum Pharmaceuticals, Inc. from October 12, 2010 to June 5, 2013 and as its Principal Accounting Officer from November 16, 2010 to June 5, 2013. He served as the Chief Financial Officer of Biolase Technology, Inc. from July 14, 2009 to July 6, 2010. He ...

Read Full Background

Corporate Headquarters*

11500 South Eastern Avenue
Henderson, Nevada 89052

United States

Phone: 702-835-6300
Fax: 702-260-7405

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BS
University of Southern California

Other Affiliations*

Annual Compensation*

Salary$250,000
Bonus$50,000
Total Annual Compensation$300,000

Stock Options*

All Other Compensation$70,116
Exercisable Options85,416
Exercisable Options Value$447,287
Unexercisable Options89,584
Unexercisable Options Value$389,713
Total Value of Options$837,000
Total Number of Options175,000

Total Compensation*

Total Annual Cash Compensation$370,116
Total Short Term Compensation$300,000
Other Long Term Compensation$70,116
Total Calculated Compensation$546,814
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SPPI:US $8.28 USD +0.01

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President and Executive Director
Cell Therapeutics, Inc.
$1.2M
John H. Johnson Executive Chairman, Chief Executive Officer and President
Dendreon Corp.
$736.4K
David Alan Dodd Chief Executive Officer, President and Director
Æterna Zentaris Inc.
--
Daniel J. Abdun-Nabi Chief Executive Officer, President, Director and Member of Strategic Operations Committee
Emergent BioSolutions, Inc.
$860.3K
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SPECTRUM PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.